A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Taiho Oncology, Inc.
Taiho Oncology, Inc.
Eli Lilly and Company
Kedrion S.p.A.
Ossium Health, Inc.
Orca Biosystems, Inc.
Kelonia Therapeutics, Inc.
Cogent Biosciences, Inc.
Cellenkos, Inc.
Vincerx Pharma, Inc.
AO GENERIUM
iSpecimen Inc